BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12766124)

  • 1. Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction.
    Borghi C; Bacchelli S; Esposti DD; Ambrosioni E;
    Diabetes Care; 2003 Jun; 26(6):1862-8. PubMed ID: 12766124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
    Borghi C; Ambrosioni E; Magnani B
    Am J Cardiol; 1996 Aug; 78(3):317-22. PubMed ID: 8759812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
    Ambrosioni E; Borghi C; Magnani B
    N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study.
    Borghi C; Cicero AF; Ambrosioni E
    Vasc Health Risk Manag; 2008; 4(3):665-71. PubMed ID: 18827916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
    Borghi C; Bacchelli S; Esposti DD; Bignamini A; Magnani B; Ambrosioni E
    Am J Hypertens; 1999 Jul; 12(7):665-72. PubMed ID: 10411363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of early angiotensin-converting enzyme inhibition in patients with non-ST-elevation acute anterior myocardial infarction.
    Borghi C; Bacchelli S; Degli Esposti D; Ambrosioni E;
    Am Heart J; 2006 Sep; 152(3):470-7. PubMed ID: 16923416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.
    Borghi C; Cicero AF; Bacchelli S; Esposti DD; Ambrosioni E;
    Fundam Clin Pharmacol; 2009 Oct; 23(5):641-8. PubMed ID: 19656211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
    Borghi C; Ambrosioni E;
    Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study.
    Borghi C; Ambrosioni E;
    Am Heart J; 2003 Jan; 145(1):80-7. PubMed ID: 12514658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.
    Borghi C; Omboni S; Reggiardo G; Bacchelli S; Esposti DD; Ambrosioni E;
    BMC Cardiovasc Disord; 2018 Jun; 18(1):112. PubMed ID: 29866077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies.
    Borghi C; Omboni S; Reggiardo G; Bacchelli S; Degli Esposti D; Ambrosioni E
    J Cardiovasc Pharmacol; 2017 Jan; 69(1):48-54. PubMed ID: 27798417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ACE inhibitors after myocardial infarction: close-up on zofenopril].
    Teyssedou A
    Ann Cardiol Angeiol (Paris); 2007 Jun; 56(3):137-44. PubMed ID: 17482555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
    Ambrosioni E; Borghi C; Magnani B
    Am J Cardiol; 1991 Nov; 68(14):101D-110D. PubMed ID: 1746414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies.
    Borghi C; Omboni S; Reggiardo G; Bacchelli S; Degli Esposti D; Ambrosioni E;
    Blood Press; 2017 Aug; 26(4):211-219. PubMed ID: 28155333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
    Borghi C; Omboni S; Novo S; Vinereanu D; Ambrosio G; Ambrosioni E;
    Cardiovasc Ther; 2016 Apr; 34(2):76-84. PubMed ID: 26789425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study.
    Borghi C; Omboni S; Novo S; Vinereanu D; Ambrosio G; Ambrosioni E
    Adv Ther; 2018 May; 35(5):604-618. PubMed ID: 29667144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of ACE-inhibitors in patients with recent myocardial infarction. Studies with zofenopril].
    Lombardi C; Castrini AI; Metra M; Carubelli V; Lazzarini V; Inama L; Dei Cas L
    G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):55S-58S. PubMed ID: 23096377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
    Borghi C; Bacchelli S; Degli Esposti D; Ambrosioni E
    Expert Opin Pharmacother; 2004 Sep; 5(9):1965-77. PubMed ID: 15330734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program.
    Franconi F; Omboni S; Ambrosioni E; Reggiardo G; Campesi I; Borghi C
    PLoS One; 2014; 9(11):e111558. PubMed ID: 25364906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction: results of the German multicenter study of the effects of captopril on cardiopulmonary exercise parameters (ECCE).
    Kleber FX; Sabin GV; Winter UJ; Reindl I; Beil S; Wenzel M; Fischer M; Doering W
    Am J Cardiol; 1997 Aug; 80(3A):162A-167A. PubMed ID: 9293972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.